MonumenTAL-3

Phase 3 Clinical Trial Comparing the Efficacy of an Investigational Medication Combined with Daratumumab or Daratumumab and Pomalidomide Versus Daratumumab, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma.

Arms / Cohorts

Arm A:Investigational Medication, Daratumumab and Pomalidomide

Accepting patients

Arm B:Daratumumab, Pomalidomide and Dexamethasone

Accepting patients

Arm C:Investigational Medication and Daratumumab

Accepting patients

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print a patient-friendly report to share with your patient.

We can help answer any questions and connect you (or your patient) with the study team.

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.